Skip to main content
Clinical Trials/NCT05683236
NCT05683236
Completed
Not Applicable

The Clinical Effect Evaluation of Multidisciplinary Collaborative Team Combined With Palliative Care Model in Patients With Terminal Cancer: A Randomised Controlled Study

Shijiazhuang People's Hospital1 site in 1 country84 target enrollmentJune 6, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multidisciplinary Collaborative
Sponsor
Shijiazhuang People's Hospital
Enrollment
84
Locations
1
Primary Endpoint
Self-rating Depression Scale
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This study proposed a multidisciplinary collaborative team combined with a palliative care model and proposed to establish a team composed of medical staff in various disciplines to make up for the defects of a conventional nursing team. This study applied the multidisciplinary collaboration team combined with a palliative care model to patients with terminal cancer to evaluate its clinical effect.

Registry
clinicaltrials.gov
Start Date
June 6, 2019
End Date
May 16, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Shijiazhuang People's Hospital
Responsible Party
Principal Investigator
Principal Investigator

Yujing Liu

head nurse

Shijiazhuang People's Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients were diagnosed as terminal by imaging, pathology and clinical manifestations
  • the expected length of stay was more than seven days
  • patients with clear consciousness, good communication and understanding ability
  • voluntary participation in this study and signing of informed consent
  • the estimated survival period is more than three months

Exclusion Criteria

  • Patients with cognitive impairment and mental illness
  • those who were seriously ill and could not cooperate with the completion
  • patients with severe communication disorders

Outcomes

Primary Outcomes

Self-rating Depression Scale

Time Frame: through study completion, an average of 1 year

There are a total of 20 entries, of which 10 are scored by forward and 10 by reverse. The entries are scored by Likert4 level. The sum of the scores of each item is the total score of the scale. The scores were converted to a standard score: standard score = total anxiety score×1.25. The higher the score, the more serious the depression. A score ≤50 showed no depression, 50-59 showed mild depression, 60-69 showed moderate depression, and \>70 showed severe depression

Social Support Rating Scale

Time Frame: through study completion, an average of 1 year

The scale was with a total of 10 items, including three dimensions of subjective support, objective support and utilisation of support. The total score of the scale is the sum of the scores of the three dimensions, and the higher the score, the greater the social support. Judgement criteria: A total score of ≤22 indicates a low level, 23-44 indicates a moderate level, and 45-66 indicates a high level, with a domestic norm score of 34.56±3.73

Self-rating Anxiety Scale

Time Frame: through study completion, an average of 1 year

This involved 20 items, of which the 5th, 9th, 13th, 17th and 19th items were reverse scoring, and the 1-5 items were positive scoring. The items were scored according to Likert4 grade. The sum of the scores of each item is the total score of the scale. The scores were converted to a standard score: standard score = total anxiety score×1.25. The higher the score, the more severe the anxiety state. A score \<50 showed no anxiety, 50-59 showed mild anxiety, 60-69 showed moderate anxiety, and \>70 showed severe anxiety

Quality of Life Scale

Time Frame: through study completion, an average of 1 year

QLQ-C30 consists of one overall QOL scale and five functional scales. The functional scales include physical function, role function, emotional function, cognitive function and social function. Rating criteria: After the scores of each part of the scale are converted to standardised scores, and the score range is 0-100. The higher the score on the scale, the better the overall QOL and functional status

Study Sites (1)

Loading locations...

Similar Trials